Immuto Scientific的动态

“Life Sciences haben riesiges Potenzial” nachzulesen in der am 18. Oktober 2024 erschienen Ausgabe der Salzburger Nachrichten. Interview with Nata?a Deutinger from Startup Salzburg: “Deutinger also sees pioneering start-ups in this field: She mentions Small New World Laboratories, run by the duo Eva Rohde and Mario Gimona. They develop and produce advanced biologics derived from human cells to improve and accelerate the body's own healing process by suppressing inflammatory immune reactivity and fibrosis. In short, it's about preventing scarring in the body.“ Thank you for the positive feedback. ? #snwlabs #nanovesiculartechnology #efre #evttsalzburg #extracellularvesicles #exosomes #nanovesiculartherapy #atmps #biologicals #theralytics #frombenchtobedside #salzburg #research #science #gmp #manufacturing #pharma #innovation #regenerativemedicine #genetherapy #celltherapy #biologics #atmp

CSafe continue to innovate and push the envelope in the cold chain space. CSafe have recently announced three new technologies to address challenges that pharma companies have in the cold chain industries. - CSafe's Multi-Use Dewars, these Dewars maintain the coldest temperature range of -150°C?or colder which will be used mainly for Cell & Gene Therapy - CSafe Connect Control Tower to give customers better visibility and real time data in the supply chain. - Silverpod MAX RE is CSafe's newest reusable shipping solution, it's a highly durable pallet shipper made entirely of reusable components. Exciting times for CSafe! there's no secret more needs to be brought to the table from cold chain companies, but I hear of and see a lot of activity going down from companies in the space, so expect more news soon! #coldchain #pharmapackaging #logistics #supplychain #pharmaceutical #biologics #cellandgenetherapy

Data is the underpinning of healthcare - headline article featuring interview with Treehill Partners CEO, Ali Pashazadeh, at Genetic Engineering & Biotechnology News (GEN) - a renown publication with unique news covering the entire bioproduct life cycle, including drug discovery, early-stage R&D, applied research , bioprocessing, and commercialization. The interview addresses key considerations on data-led decision making in the boarder healthcare industry, approaches to steer and execute healthcare policy, and the continued unmet need for improved efficiency in the ecosystem of pharmaceutical innovation, validation, commercialisation, and patient benefit. https://lnkd.in/estjhExD

Shining the light behind the curtains - impressive work by the Advaxia Biologics #QC experts! Curious to learn more? Just get in touch with me! I look forward to discussing how we can support your #biologics programs!

Are you ready to take the next step beyond your research discovery program? Neva’s team is prepared to help you launch your preclinical program. As a uniquely experienced, scale-friendly CDMO, we offer both platform bioprocessing solutions or the ability to explore custom bioprocessing of molecules?to provide you with preclinical testing materials. #nevaanyalytics #nevaresearchbioprocessing #analyticallab #bioprocessing #research #biologics #biologicsmanufacturing #intellectualproperty #IP #leadcandidate #earlystage #preclinical #processdevelopment #proteinexpression #mammalian #microbial #cellculture #purification

? Just published! ? Are you looking for the latest insights into bioprocessing/bioproduction? Download our new In-Depth Focus to discover: ?? The potential of biologics production: a?comprehensive exploration Different types of biologics require different sized bioreactors and different manufacturing approaches, as Sridevi Khambhampaty, Vice President at Syngene International Limited, elucidates. ?? Bioconjugation of antibody-drug conjugates: the past, present and future Parviz A. Shamlou, Senior Vice President, Science and Technology at Abzena, explores how the evolution of bioconjugation technology is leading to therapeutic advancements in oncology and beyond. Download now >> https://bit.ly/4dhOUAm This In-Depth Focus has been sponsored by Actylis. #Bioprocessing #Bioproduction #Biologics #Antibody

With their unique structural features, robust binding affinity, and diverse applications, VHH single domain antibodies hold immense promise as next-generation biologics for addressing unmet medical needs and advancing precision medicine. Ease of Production and Engineering: VHHs can be produced recombinantly using microbial expression systems, such as bacteria or yeast. They can also be engineered to enhance their properties, such as stability, affinity, or half-life, through techniques like antibody phage display or site-directed mutagenesis. https://lnkd.in/eXEFfAYV #VHH #singledomain #antibodies #biologics #precisionmedicine #production #engineering #recombinant #microbial #expression #phageDisplay #bindingaffinity #applications #medicinalneeds #alphalifetech

With their unique structural features, robust binding affinity, and diverse applications, VHH single domain antibodies hold immense promise as next-generation biologics for addressing unmet medical needs and advancing precision medicine. Ease of Production and Engineering: VHHs can be produced recombinantly using microbial expression systems, such as bacteria or yeast. They can also be engineered to enhance their properties, such as stability, affinity, or half-life, through techniques like antibody phage display or site-directed mutagenesis. https://lnkd.in/et_WVeFT #VHH #singledomain #antibodies #biologics #precisionmedicine #production #engineering #recombinant #microbial #expression #phageDisplay #bindingaffinity #applications #medicinalneeds #alphalifetech

We have had a glimpse into this paradigm shift when deep diving with Zach K.T. Pang, PhD MBA at A*StartCentral Essentials Bootcamp Hear it from Zach, himself A*STAR Bioprocessing Technology Institute (BTI)

Droplet Microfluidics for Single Cell Analysis: The Next Generation of Capability — Featured in Select Science! ???? In this piece, we explore how droplet microfluidics is transforming biopharma by: - Encapsulating single cells in tiny droplets for precise analysis and selection - Maintaining cell viability with a benign environment for robust assays - Accelerating workflows with high-speed, automated processes - Enabling deep multiplexing for simultaneous analysis of secreted and surface markers ?? Read the full article here: https://bit.ly/4eBYpdH #SphereFluidics #SingleCellAnalysis #DropletMicrofluidics #Biologics #Innovation #CellSelection